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Objective: To assess the extent and pattern of regression of left ventricular 
hypertrophy after valve replacement for aortic stenosis, we studied 26 
patients receiving either 19 or 21 mm CarboMedics valves (group I, 13 
patients) or either 23 or 25 mm CarboMedics valves (group II, 13 patients). 
The studies were done before the operation and after 3 years, and results 
were compared with those of 10 control patients. Methods: Left ventricular 
end-diastolic and end-systolic diameters and volumes, ejection fraction and 
fractional shortening, and interventricular septum and posterior wall 
thickness were measured. The ratio between interventricular septum and 
posterior wall thickness, the ratio between left ventricular wall thickness 
and left ventricular chamber adius, and the left ventricular mass were 
then calculated. Results: At follow-up there was a significant reduction in 
the left ventricular mass, interventricular septum, and posterior wall 
thickness for both patient groups (p < 0.01). However, only the posterior 
wall thickness reached normal values; the interventricular septum and the 
left ventricular mass indices were still significantly greater than i the 
control group (p < 0.01). Because of the incomplete regression of interven- 
tricular septal hypertrophy, the ratio between interventricular septum and 
posterior wall thickness was similar between both patient groups but it was 
significantly higher than in control subjects (p < 0.01). The ratio between 
wall thickness and chamber adius did not decrease significantly in group 
II patients, in whom it remained above the control values. Conclusion: 
Having a bileaflet aortic prosthesis of one size larger did not seem to 
significantly influence the pattern and the extent of regression of left 
ventricular hypertrophy after an intermediate period of follow-up. 
(J Thorac Cardiovasc Surg 1997;113:901-9) 
R esidual postoperative gradients are often present after aortic valve replacement with a 
prosthetic valve. These gradients are progressively 
higher as the size of the prosthetic valve decreases. 
Therefore small prosthetic valves might become 
relatively stenotic, especially when implanted in 
patients with a large body surface area (BSA). The 
presence of a significant postoperative gradient has 
been thought to be responsible for adverse long- 
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term mortality and morbidity. In fact, the residual 
postoperative gradient might influence the extent of 
regression of left ventricular hypertrophy that, in 
turn, is responsible for a higher incidence of arrhyth- 
mias and impaired ventricular function. In this study 
we wanted to analyze the pattern and extent of 
regression of hypertrophy in a group of patients 
receiving small CarboMedics aortic prosthetic valves 
(CarboMedics, Inc., Austin, Tex.) and compare the 
results with those of another group receiving larger 
valves and with a control group. 
Patients and methods 
Patient population. Twenty-six ambulatory patients 
who had prior aortic valve replacement for severe aortic 
stenosis were considered. Patients elected for the study 
were those who had the preoperative echocardiographic 
evaluation at our institution, who did not have other 
associated valvular or coronary diseases, and who had no 
history of systemic hypertension. Three groups of patients 
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Table I. Patient characteristics 
Group I Group H Control 
Age (yr) 63.5 + 11.3 61.4 _+ 9.5 58.6 _+ 11.6 
Sex (M/F) 5/8 11/2" 4/6 
BSA(m 2) 1.67-+0.1 1.78-+0.1 1.72_+0.1 
EAI (cm 2) 0.76 _+ 0.1 1.04 _+ 0.1t - -  
Associated AI 1 2 - -  
Maximum gradient preop 93 -+ 28 91 _+ 25 - -  
(ram Hg) 
Maximum gradient 35 _+ 13 30 _+ 11 - -  
postop (ram Hg) 
BSA, Body surface area; EAI, effective area index; A/, aortic insuflficiency. 
*p = 0.044 versus group I. 
tp = 0.0001 versus group I. 
were considered. The first group (group I) comprised 13 
patients receiving either a 19 mm (n = 5) or a 21 mm 
CarboMedics (n = 8) prosthetic valve. The second group 
(group II) comprised 13 patients who received either a 23 
mm (n = 10) or a 25 mm (n = 3) CarboMedics prosthetic 
valve. The third group of 10 healthy subjects, with no heart 
valve disease on routine diagnostic echocardiography and no 
history of systemic hypertension, served as a control. 
All patients were evaluated before the operation and 
after a mean period of 30 _+ 7 months for group I and of 
32 _+ 5 months for group II (p = not significant). Medical 
ethics committee approval and informed patient consent 
for participation i  the study were obtained in all cases. 
Patient characteristics are shown in Table I. A higher 
number of female patients was present in the smaller valve 
group, consistent with the fact that women have a smaller 
BSA and smaller aortic root. Although the BSA was 
smaller in the patients in group I, it was not significantly 
different from that of the other two groups. As a result, 
when the orifice areas of the prosthesis (effective orifice 
area as measured in vitro and obtained from the manu- 
facturer) were indexed for the BSA to obtain the effective 
area index, a significant difference from patients in group 
II was found. Therefore, in patient s in group I a signifi- 
cantly higher mismatch between prosthetic valve area and 
BSA was found (effective area index = 0.7 cm2/m a, Table 
I). Although the majority of patients had pure aortic 
stenosis, a moderate degree of regurgitant volume was 
present in one patient in group I and in two patients in 
group II. 
Echocardiographic measurements and calculations. 
At each follow=up eriod, M-mode, two-dimensional, nd 
Doppler echocardiography were performed with a 
Hewlett-Packard series 77025A echocardiograph with a 
2.0 to 2.5 MHz transducer (Hewlett-Packard, Inc., An- 
dover, Mass). Standard apical, parasternal, and subcostal 
views were obtained. The following parameters were 
measured: left ventricular end-diastolic and end-systolic 
diameters and volumes; ejection fraction and fractional 
shortening; interventricular septum and posterior wall 
thickness; and maximum and mean flow velocity across 
the valve. Then the following parameters were calculated: 
(1) the ratio between interventricular septum and thick- 
ness (IVS/PW) measured at the suprapapillary level (lev- 
els above the control values were considered to represent 
an asymmetry in the left ventricular hypertrophy); (2) 
the ratio between the left ventricular wall thickness 
(IVS + PW) and the left ventricular chamber radius (Th/r) 
(levels above the control values were considered to rep- 
resent a pattern of concentric hypertrophy, whereas those 
equal to Or less than the control values were considered to 
represent an eccentric hypertrophy); (3) the left ventric- 
ular mass was calculated from the M-mode measurements 
using the formula modified by Devereux and Reichera; (4) 
maximum and mean valve gradients were calculated by 
means of the modified Bernoulli equation. All values were 
indexed for the BSA. All parameters were measured 
and calculated independently by two expert echocardi- 
ographers. The echocardiograms were reviewed by a third 
investigator if the first two investigators were not in 
agreement. 
Statistical analysis. One-factor analysis of variance was 
used to compare echocardiographic parameters among 
patient groups at each observation point. When significant 
differences were detected, pairwise comparisons were 
made by the Scheff6 F test. One-way analysis of variance 
for repeated measures was used to compare chocardio- 
graphic parameters at the time of operation and at 
follow-up. Comparisons of the remaining continuous or 
discrete variables between the two groups were performed 
with an unpaired Student's t test or a )(2 test, respectively 
(SPSS for Windows Software, SPSS, Inc., Chicago, Ill.). 
Data are expressed as mean _+ 1 standard deviation, 
unless otherwise indicated; p values < 0.05 were consid- 
ered significant. 
Results 
New York Heart Association (NYHA)  functional 
class improved in all patients. At each follow-up 
period the majority of patients (21/26, 81%) were in 
NYHA class I, and the remaining were in class II 
(19%). 
Echocardiographic measurements of left ventric- 
ular diameters and volumes and assessment of left 
ventricular function at fol low-up for groups I and II 
and those for the control group are shown in Table 
II. 
Preoperatively, left ventricular dimension and 
function were comparable between groups I and II 
and similar to those of the control group. Although 
only the end-systolic diameters and volumes were 
significantly higher, in patients of group II there was 
a trend to more ventricular enlargement with a 
slightly more depressed ventricular function. How- 
ever, at follow-up all values for each group were 
within the normal range (Table II). 
Preoperatively, the left ventricular mass index was 
significantly greater in both groups of patients than 
in the control subjects (Fig. 1, Table III). Although 
at the postoperative study both patient groups ex- 
hibited a significant decrease in left ventricular 
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Fig. 1. Mean values (_+SEM) of left ventricular mass index in patients with size 19 to 21 mm (open square) 
or sizes 23 to 25 mm (closed square) CarboMedics aortic prostheses referenced against he control group 
(shaded area) tpreoperative and postoperative follow-up. A significant reduction in left ventricular mass 
is evident for both groups of patients, although mass remained above the normal values. *p = 0.0001 versus 
control; **p = 0.02 versus control. 
Table II. Left ventricular diameters and volumes and left ventricular function for patients with size 19 or 21 
mm (group, I) and size 23 or 25 mm (group II) prosthetic aortic valves and control subjects 
Echocardiographic parameters 
L VEDDI L VESDI L VED VI L VESVI EF FS 
(mm/m 2) (mm/m 2) (ml/m 2) (ml/m 2) (%) (%) 
Group I 
Preoperat ive 28 ± 4.3 17.8 _+ 2.7 64.1 ± 14 20.6 + 8.6 67 _+ 10 38.5 ± 8 
Fol low-up 27 _+ 5.9 19.4 _+ 3.8 64.7 ± 24 25.8 _+ 14.3 61 ± 10 33.4 ± 8.6 
Group II  
Preoperat ive 30.9 _+ 6.7 20.8 + 4.3* 83.9 ± 33 35.6 -- 197 58 ± 10 31.7 _+ 8.5 
Fol low-up 27.5 _+ 3.4 18.4 + 3 66 ± 17 25.9 _+ 10 60 _+ 8 32.7 -- 6.1 
Control  28.3 ± 2.7 18.3 ± 1.7 65.4 ± 11 23.5 ± 7.2 63 ± 10 35.3 _+ 7.4 
LVEDDI, Left ventricular end-diastolic diameter index; LVESDI, left ventricular end-systolic diameter index; LVEDVI, left ventricular end-diastolic volume 
index; LVESVI, left ventricular end-systolic volume index; EF, ejection fraction; FS, fractional shortening. 
*p = 0.05 versus group I. 
tp = 0.02 versus group I. 
mass, it remained significantly greater than in the 
control group. 
The thickness of the interventricular septum and 
of the posterior wall, which were significantly 
greater before the operation in both group of pa- 
tients than in the control group, decreased signifi- 
cantly at the postoperative study (Fig. 2, A and B, 
Table III). However, whereas the posterior wall 
thickness was within the normal range and not 
significantly different from that of the control group, 
the interventricular septum was still significantly 
thicker in both patient groups than in controls. 
Preoperatively, the ratio of interventricular septum 
and posterior wall thickness (IVS/PW) in both 
groups was similar to that of the control group. 
However, because of the incomplete regression of 
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Table III. Left ventricular mass index, interventricular septum, and posterior wall thickness, their ratio, and the 
ratio between left ventricular wall thickness to radius for patients with size 19 or 21 mm (group I) and size 23 
or 25 mm (group II) prosthetic aortic valves and control subjects 
Echocardiographic parameters 
LV mass index 1VS PW 
(gm/m 2) (mm ) (ram) 1VS /PW Th/r 
Group I 
Preoperative 186 ± 45 14.4 _+ 2.1 12.7 _+ 2.1 1.15 _+ 0.2 0.56 ± 0.08 
Follow-up 136 _+ 47 12.3 _+ 1.8 9.8 _+ 1.5 1.26 _+ 0.2 0.45 _+ 0.09 
Group II 
Preoperative 234 +_ 72 15.4 _+ 3.4 12.7 _+ 2.3 1.23 _+ 0.3 0.53 _+ 0.16 
Follow-up 152 _+ 35 13.1 _+ 1.7 10.5 ± 1.7 1.27 ± 0.2 0.48 ± 0.1 
Control 105 -+ 18 9.3 ± 1.1 9 _+ 1.1 1.04 _+ 0.1 0.37 _+ 0.05 
LV, Left ventricular;/VS, interventricular septum; PW, posterior wall; Th/r, ratio between left ventricular thickness to radius (p values are indicated in Figs. 
1 to 4). 
the interventricular septum hypertrophy and the 
complete regression of the posterior wall hypertro- 
phy, at follow-up their ratio was significantly higher 
in both valve groups than i control subjects (Fig. 3, 
Table Ill). 
Preoperatively, the ratio of left ventricular wall 
thickness to radius (Th/r) was significantly higher in 
both groups of patients than in the control group. In 
group I it decreased over time, and at the follow-up 
it was within the control values and significantly 
different from the preoperative values (Fig. 4, Table 
III). In group II the postoperative ratio of left 
ventricular wall thickness to radius (Th/r) did not 
decrease significantly, and therefore at the postop- 
erative study it was still significantly higher than in 
the control group. (This result was due to an earlier 
and complete normalization of ventricular volumes, 
which were slightly larger than in group I, compared 
with the slower and incomplete regression of the 
septal thickness.) 
For patients in group I who had been evaluated 
for another study protocol, a shorter follow-up 
(10.4 +_ 6.2 months) was also available, and no 
significant differences for all parameters considered 
could be detected between the two follow-up peri- 
ods. 
Discussion 
The development of concentric hypertrophy in 
patients with aortic stenosis or systemic hyperten- 
sion is an appropriate adaptation of the left ventric- 
ular muscle to the increase in the intracavitary 
pressure, 2 which allows it to maintain a normal 
relation between systolic wall stress and ejection 
fraction. However, in hypertensive patients the pres- 
ence of concentric hypertrophy is associated with 
increased morbidity and mortality. 3'4 Similarly, in 
patients with aortic stenosis, it has been found 
associated with increased postoperative mortality 
after aortic valve replacement. 5 These findings were 
related to several mechanisms, including a subopti- 
mal myocardial protection of the hypertrophied 
heart, an abnormality in coronary flow reserve, and 
an exacerbation of diastolic dysfunction. Besides the 
increased perioperative mortality and morbidity as- 
sociated with marked concentric ventricular hyper- 
trophy, it is possible that the lack of regression of 
left ventricular hypertrophy after aortic valve re- 
placement might negatively influence the long-term 
prognosis of this subset of patients. In the majority 
of cases, implantation of an aortic valve prosthesis 
corrects the abnormal hemodynamic burden and 
causes a regression of the left ventricular hypertro- 
phy. However, the use of small aortic valve prosthe- 
ses and therefore the possibility of a patient-pros- 
thesis mismatch raises the concern that the 
regression of hypertrophy and the remodeling of the 
left ventricular geometry might not take place. 
This assumption is often based on the evidence 
that residual postoperative gradients are often 
found after aortic valve replacement with small 
prosthetic valves. These gradients are more marked 
with the use of porcine valves or with the first 
generation of mechanical valves. In the late seven- 
ties, several authors recommended that 19 or 21 mm 
porcine valves 6' 7 not be used in adults because they 
could cause severe transprosthetic gradients, espe- 
cially during exercise. 8 Many different anulus-en- 
larging procedures 9' 10 have been recommended to
allow the implantation of larger prostheses. The use 
of the tilting disc mechanical valve greatly decreased 
the rest and exercise gradients, so that the long-term 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 5 
De Paulis et aL 905 
17 
16 ¸  
g t5 
N 
14 
'~ 13 
?. l0 
N 
N 9 
8 
A 
p = 0.05 
[] 
p = 0.02 
i!:!:i:i:•:•:•:i:i:!:•:!:i:!:!:!:!:!:i:i:•:•:•:i:•:i:i:!:i:i:i:!:!:i:i:i:•:•:i:•:•:i:i:i:i:!:i:i:i:i:!:i:i:!:•:i:•:•:•:i:•:i:i:i:i:!:!:i:!:i:i:•:•:•:•:i:i:i:i• 
I I 
Preoperative 2 to 3 years postop 
19-21 mm valves 
23-25 mm valves 
Control group 
17 
16 
15 
14 
13 
12 
11 
10 
9 
8 
p = 0.02 
I I 
B Preoperative 2 to 3 years postop 
19-21 mm valves 
23-25 mm valves 
Control group 
Fig. 2. Mean values (+SEM) of interventricular septum (A) and left ventricular posterior wall (B) 
thickness in patients with size 19 to 21 mm (open square) or sizes 23 to 25 mm (closed square) CarboMedics 
aortic prostheses referenced against he control group (shaded area) t preoperative and postoperative 
follow-up. A significant reduction in interventricular septum and posterior wall thickness i evident for both 
groups of patients. However, at follow-up, whereas the posterior wall was within the normal range, the 
interventricular septum remained significantly thicker than control values for both patient groups. *p = 
0.0001 versus controls. 
survival and clinical status reportedly has been un- 
affected by the use of small prosthesis izes, u How- 
ever, some authors ~2 still found unsatisfactory the 
hemodynamic performances of 19 mm tilting disc 
valves. 
The advent of bileaflet valves with their improved 
hemodynamic performances has somehow over- 
come the disadvantages of using small valves. Most 
studies evaluating the St. Jude Medical mechanical 
valve (St. Jude Medical, Inc., St. Paul, Minn.) re- 
ported catheterization mean gradients varying from 
7 to 14 mm Hg for the 19 mm valve, 13' 14 and similar 
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Fig. 3. Mean values (_+SEM) of interventricular septum to left ventricular posterior wall thickness ratio 
(IVS/PW) in patients with size 19 to 21 mm (open square) or sizes 23 to 25 mm (closed square) CarboMedics 
aortic prostheses referenced against he control group (shaded area) at preoperative and postoperative 
follow-up. Both groups of patients howed a tendency with time toward an asymmetry of their left 
ventricular hypertrophy. *p = 0.005 versus controls; NS, not significant. 
values were also found on the catheterization-de- 
rived gradients for the CarboMedics valve. 15 How- 
ever, most of the time the Doppler-derived gradi- 
ents are used to evaluate and to compare different 
valve prostheses. We recently found postoperative 
Doppler gradients for small CarboMedics valves in 
the range of 35 mm Hg after exercise. 16 Similarly, 
Doppler-derived gradients for the 21 mm St. Jude 
Medical and CarboMedics valves in the range of 7 
mm Hg at rest and 24 mm Hg after dobutamine 
stress echocardiography ave been reported. 17 Al- 
though a good correlation between catheter-derived 
and Doppler-derived gradients has been reported] 8,19 
it is widely known that Doppler-defined gradients in 
bileaftet valves are often overestimated by comparison 
with catheter-derived gradients. 2°This is due to the 
presence of high localized gradients and to the phe- 
nomenon of pressure recovery distal to the aortic 
prosthesis. Another source of error in the Doppler- 
derived gradients might also derive from their depen- 
dence on the opening angle of the valve. In case of 
valve malfunction with restricted leaflet movements, 
the increase of Doppler-derived gradients has been 
found to be considerably smaller than the increase in 
catheter-derived gradients. 21Considering that a pros- 
thesis evaluation based solely on the measurement of 
residual Doppler-derived gradient might not be satis- 
factory, we thought that a more accurate valuation of 
small aortic prostheses should be based on the close 
observation of the extent, pattern, and rate of regres- 
sion of left ventricular hypertrophy. Monrad and asso- 
ciates 22 followed the regression of hypertrophy at an 
intermediate (1.6 years) and a late (8 years) period 
after aortic valve replacement with different valve 
prostheses. They noted that the regression of hyper- 
trophy was conspicuous after surgery by the time of the 
intermediate study but continued at a slower rate 
thereafter. They concluded that the improvements 
occurring at a slight but constant afterload excess for 
the presence of the valve prosthesis indicates that the 
hypertrophied myocardium is operating at a reduced 
level. However, even late after aortic valve replace- 
ment, a moderate degree of hypertrophy was still 
present• Our study demonstrated that, within certain 
limits, there is no difference in the extent and pattern 
of regression of left ventricular hypertrophy in patients 
with different mismatches between valve prosthesis 
and BSA. Although after 3 years of follow-up a 
normalization of the myocardial mass was not ob- 
tained, a significant regression of left ventricular hy- 
pertrophy was present in all patients. The lack of 
normalization of myocardial mass was mainly due to 
the incomplete regression of the hypertrophy of the 
interventricular septum. It is known that in the inter- 
ventricular septum there is a higher fibrous reaction 
and the fibrous content takes longer to decrease 
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Fig. 4. Mean values (_+SEM) of left ventricular wall thickness/chamber radius ratio (Th/r) in patients with 
size 19 to 21 mm (open square) or sizes 23 to 25 mm (closed square) CarboMedics aortic prostheses 
referenced against the control group (shaded area) at preoperative and postoperative follow-up. Both 
groups of patients howed a reduction with time in the pattern of concentric hypertrophy. In the larger 
size-prosthesis group, the hypertrophy remained significantly higher than in the control subjects because 
the magnitude of decrease in left ventricular diameters and volumes was greater than in the other patient 
group (Table II). See text for details. *p = 0.0009 versus controls; **p = 0.02 versus controls. 
significantly. 23 Nonetheless, the same results were 
found for patients with effective area indexes varying 
from 0.7 to 1 cm2/m 2. Therefore it is possible that for 
the bileaflet valve the minimum requirement of 0.9 
cm2/m 2previously suggested and based on reports 24' 25 
evaluating different types of bioprostheses or first- 
generation mechanical valves could be safely lowered. 
Grouping together all valves and correlating the 
effective area index with the interventricular septum 
thickness and with the left ventricular mass, we were 
unable to find a point at which effective area index 
of the prosthesis was too small to negatively influ- 
ence the regression of left ventricular hypertrophy 
(r = 0.42,p = 0.03). Therefore this study shows that 
even patients with an effective area index as low as 
0.7 cm2/m 2were able to obtain a satisfactory regres- 
sion of left ventricular hypertrophy. Although an 
effective orifice area between 0.6 and 0.75 cm2/m 2is 
considered a severe aortic stenosis for a natural 
valve, it might still significantly decrease the left 
ventricular hypertrophy when it is related to a 
bileaflet prosthetic valve with optimized flow hemo- 
dynamics. 
Although a larger valve prosthesis yields better 
hemodynamic performances, from a clinical point of 
view it is difficult to demonstrate a significantly 
worse result in the majority of patients with small 
valve prostheses. In a group of patients with small 
St. Jude Medical valves after 12 years of follow-up, 
Kratz and associates 26reported that having a small 
valve was not predictive of persistent congestive 
heart failure or late death. A small increase in the 
risk of sudden death was found only in patients with 
a BSA of more than 1.9 m 2 receiving a 19 mm 
prosthesis. Similarly, in a large group of patients 
followed up for 18 years, who received different 
kinds of valves smaller than 21 ram, He and associ- 
ates 27 found that a mismatch between BSA and 
prosthesis ize is a negative determinant for long- 
term survival only in patients with concomitant 
coronary artery bypass grafting. Previously, Foster 
and coworkers, 11 evaluating 17 and 19 mm Bj6rk- 
Shiley valve prostheses, found that 93% of the 
patients with resting gradients higher than 30 mm 
Hg were in NYHA class I and concluded that resting 
hemodynamic studies have a limited predictive 
value for long-term prognosis. It is therefore vident 
that information on the extent of regression of left 
ventricular hypertrophy might be more valuable for 
the surgeon dealing with a small aortic anulus. 
In a recent review article, Barner and colleagues 28
stated that after a 6-month observation period pa- 
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tients with small mechanical valves had lower reduc- 
tion in left ventricular mass index, decreased exer- 
cise tolerance, and higher functional class than 
patients with larger valves. In particular, they found 
that valve size was an independent determinant 
(although with a weak correlation, r = 0.26) of 
functional class. The difference from our study could 
be due either to the different follow-up period or to 
a different surgical timing. 
A difference in the regression of left ventricular 
hypertrophy after aortic valve replacement for aor- 
tic stenosis has also been noted in patients with 
preoperative depressed ventricular function. 29 Al- 
though our group II patients had slightly enlarged 
ventricles, their ventricular function was normal and 
we could not include this variable in the analysis. 
Finally, Sim and associates 3°analyzed the influence 
of prosthesis ize on the change in left ventricular 
mass and concluded that 19 mm valves might not 
provide comparable reduction in left ventricular 
mass after aortic valve replacement. However, in 
their study, although the magnitude of reduction in 
left ventricular mass was greater in patients with 
valve size 21 mm or larger, it did not reach statistical 
significance. More important, all groups approached 
similar values in the postoperative measurements of 
left ventricular mass index. These findings seem to 
indicate that, although patients with different valve 
sizes might have a different rate of reduction in left 
ventricular hypertrophy, all patients obtain a regres- 
sion of left ventricular hypertrophy to a certain 
point, after which it continues at a much slower 
rate. 22 Although the numbers might be too small for 
meaningful conclusions, also when we compared 
patients with 19 mm valves (n = 5) and those with 21 
mm valves (n = 8) (which combined in group I), we 
did not find any significant difference in all param- 
eters considered. 
The lack of substantial differences observed be- 
tween our two groups of patients, even in the extent 
and pattern of regression of ventricular hypertro- 
phy, testifies to the overall good performances of 
small bileaflet valves and confirms that in the pres- 
ence of a postoperative r sidual gradient a longer 
time is probably needed for a more complete regres- 
sion of left ventricular hypertrophy. 
Conclusions 
It seems intuitive that a more complete relief of 
obstruction is obtained with the implantation of a 
larger valve prosthesis. Therefore, especially in the 
small aortic root, surgeons usually attempt o ira- 
plant the largest possible valve. However, this study 
suggests that in most patients the possibility and the 
ability to implant a prosthesis one size larger might 
not be justified by a significant difference, not only in 
the clinical status but also in the pattern and extent 
of regression of ventricular hypertrophy. Therefore 
the risk associated with an anulus-enlarging proce- 
dure or with the use of improved versions of cur- 
rently available bileaflet valves, whose results are 
still uninvestigated, should be weighed against he 
trivial differences in the postoperative clinical status 
and the extent of regression of left ventricular 
hypertrophy. The new Hemodynamic Plus St. Jude 
Medical valve (St. Jude Medical HP) that has the 
same orifice as the next larger standard valve and 
the supraanular version of the CarboMedics valve 
(Top-hat) should demonstrate the same valve-re- 
lated complications as the standard version before 
their use will be widespread. 
Given the fact that in most cases the size of the 
prosthesis for aortic valve replacement is correlated 
to the body size of the patient, there are very few 
cases in which the mismatch between valve prosthe- 
sis and BSA seems to be significant to the point that 
a prosthesis of one size larger might influence the 
regression of left ventricular hypertrophy. 
Study limitations 
A limitation of this study is that the rate of 
regression at a longer follow-up was not analyzed. It
is possible that in patients with larger valve prosthe- 
ses the regression of hypertrophy will continue many 
years after the operation, as demonstrated byMon- 
rad, 2a Krayenbuehl, 23and their associates, whereas 
in the smaller valve group it might not take place. A 
longer follow-up period is required to unveil this 
aspect. Furthermore, we did not analyze the differ- 
ences in the rate of regression between the two 
group within the first year. However, if these differ- 
ences did exist, they would require monthly echo- 
cardiographic studies within the year and they would 
probably not have clinical relevance. Finally, the 
small group of patients considered might account 
for a less accurate statistical validation of the results. 
However, the patient selection needed to be very 
accurate, because the patients were categorized not 
only according to valve type and size, but also 
according to the absence of significant valve regur- 
gitation, the absence of hypertension, and other 
cardiac abnormalities or procedures. Nonetheless, 
the evaluation of this small group of patients al- 
lowed us to conclude that bileaflet valves might offer 
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good hemodynamic performance tothe point that in 
a large number of cases a small difference in pros- 
thesis size not only is not clinically relevant, but 
might not significantly influence the regression of 
left ventricular hypertrophy. 
We thank A. Parma, MD, MSc, for his assistance in the 
statistical analysis of our data. 
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